Company Filing History:
Years Active: 2020-2025
Title: Innovations by John Stephen Pendergrast
Introduction
John Stephen Pendergrast is an accomplished inventor based in Stockholm, NJ (US). He has made significant contributions to the field of biomedicine through his innovative patent. His work focuses on the isolation of extracellular vesicles and other bioparticles from biofluids, which has important implications for diagnostics and therapeutics.
Latest Patents
Pendergrast holds a patent titled "Methods for the isolation of extracellular vesicles and other bioparticles from urine and other biofluids." This patent describes compositions and methods for isolating protein-nucleic acid complexes and microvesicles released by mammalian cells. The isolated bioparticles contain biological molecules that serve as diagnostic and prognostic biomarkers, as well as for identifying therapeutic targets, such as disease-associated miRNAs. The methods outlined in the patent also provide ways to produce biofluids that are free of detectable bioparticles, which is beneficial for experimental systems requiring bioparticle-depleted fluids.
Career Highlights
Pendergrast is associated with Ymir Genomics, LLC, where he continues to advance his research and innovations. His work has the potential to enhance the understanding of various diseases and improve diagnostic methods.
Collaborations
Some of his notable coworkers include Patrick Shannon Pendergrast and Robert Scott Pendergrast, who contribute to the collaborative efforts within the company.
Conclusion
John Stephen Pendergrast's innovative work in the field of biomedicine exemplifies the impact of patents on advancing scientific research and improving healthcare solutions. His contributions are paving the way for future developments in diagnostics and therapeutics.